[Enterotoxigenic Escherichia coli heat-labile enterotoxin B subunit can efficiently induce and enhance the mucosal immune response to enterovirus 71].

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

Key Laboratory of Biochemistry and Molecular Biology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.

Published: December 2014

Objective: To detect the immunogenicity of enterotoxigenic Escherichia coli heat-labile enterotoxin B subunit (LTB) and evaluate the immune effect of enterovirus 71 (EV71) capsid protein VP1 together with LTB by the intranasal route.

Methods: The LTB gene was cloned into the plasmid pET32a. The 6×His-LTB fusion protein was purified with Ni(2+)-NTA resin and used to vaccinate the New Zealand white rabbits to prepare the LTB-specific antiserum. The titer was determined by ELISA. BALB/c mice were immunized with normal saline, purified EV71 VP1 alone and EV71 VP1 together with LTB by the intranasal drip respectively. The sera as well as lung and intestinal mucosa lavage fluids were collected and determined for IgG and secretory IgA (sIgA) by indirect ELISA.

Results: Recombinant plasmid pET32a-LTB was constructed successfully. The expressed fusion protein 6×His-LTB, with a relative molecular mass of about 30 000, existed mostly in a form of inclusion body. The serum antibody titer induced with it was 1:125 000 in the New Zealand white rabbits. The levels of specific IgG and sIgA in mice immunized with EV71 VP1 plus LTB were significantly higher than those in the ones with EV71 VP1 alone and normal saline.

Conclusion: Fusion protein 6×His-LTB was successfully expressed in E.coli BL21 (DE3) and showed both good immunogenicity and adjuvant activity. The LTB can efficiently enhance specific serum antibody response and induce mucosal immune response by intranasal drip.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ev71 vp1
16
vp1 ltb
12
fusion protein
12
escherichia coli
8
coli heat-labile
8
heat-labile enterotoxin
8
enterotoxin subunit
8
mucosal immune
8
immune response
8
ltb intranasal
8

Similar Publications

Metabolomics combined with network pharmacology reveals a role for astragaloside IV in inhibiting enterovirus 71 replication via PI3K-AKT signaling.

J Transl Med

June 2024

School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China.

Background: Astragaloside IV (AST-IV), as an effective active ingredient of Astragalus membranaceus (Fisch.) Bunge. It has been found that AST-IV inhibits the replication of dengue virus, hepatitis B virus, adenovirus, and coxsackievirus B3.

View Article and Find Full Text PDF

NSUN2 mediates distinct pathways to regulate enterovirus 71 replication.

Virol Sin

August 2024

Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China; Hubei Jiangxia Laboratory, Wuhan, Hubei, 430200, China. Electronic address:

Increasing evidences suggest that the methyltransferase NSUN2 catalyzes 5-methylcytosine (m5C) modifications on viral RNAs, which are essential for the replication of various viruses. Despite the function of m5C deposition is well characterized, other potential roles of NSUN2 in regulating viral replication remain largely unknown. In this study, the m5C modified residues catalyzed by NSUN2 on enterovirus 71 (EV71) RNAs were mapped.

View Article and Find Full Text PDF
Article Synopsis
  • Hand, foot, and mouth disease (HFMD) outbreaks in Jiashan between 2016 and 2022 were primarily caused by coxsackievirus A6 (CA6) and coxsackievirus A16 (CA16), with children aged 1-5 years being the most affected group.
  • The incidence of HFMD varied annually, peaking in the summer months, while urban areas reported higher infection rates than rural ones.
  • Genetic analysis of the viruses revealed notable genetic variations in CA16 and CA6, indicating potential links to increased infectivity, with phylogenetic data classifying CA16 into two distinct groups.
View Article and Find Full Text PDF

Hand, foot, and mouth disease (HFMD) poses a significant public health threat primarily caused by four major enteroviruses: enterovirus 71 (EV71), coxsackieviruses A16, A10, and A6. Broadly protective immune responses are essential for complete protection against these major enteroviruses. In this study, we designed a new tetravalent immunogen for HFMD, validated it in silico, in vivo evaluated the immunogenicity of the DNA-based tetravalent vaccine in mice, and identified immunogenic B-cell and T-cell epitopes.

View Article and Find Full Text PDF

Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication.

Autophagy

July 2024

State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.

Many viruses, including foot-and-mouth disease virus (FMDV), can promote the degradation of host proteins through macroautophagy/autophagy, thereby promoting viral replication. However, the regulatory mechanism between autophagy and innate immune responses is not fully understood during FMDV infection. Here, we found that the host GTPBP4/NOG1 (GTP binding protein 4) is a negative regulator of innate immune responses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!